Ace inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients
Ali K. Abu‐Alfa(Yale University), Margaret J. Bia(Yale University), David B. Simon(Howard Hughes Medical Institute), Mark A. Perazella(Yale University), Dinna N. Cruz(UNSW Sydney), Rex L. Mahnensmith(Yale University)
Cited by 50
Related Papers
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869
Genetic heterogeneity of Barter's syndrome revealed by mutations in the K+ channel, ROMK
|Nature Genetics|1996|824